Average Co-Inventor Count = 4.51
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aragon Pharmaceuticals, Inc. (15 from 34 patents)
2. Genentech, Inc. (11 from 3,221 patents)
3. Merck + Co., Inc. (10 from 4,770 patents)
4. Metacrine, Inc. (8 from 8 patents)
5. Sloan-kettering Institute for Cancer Research (7 from 512 patents)
6. Seragon Pharmaceuticals, Inc. (6 from 6 patents)
7. Merck Sharp + Dohme Corp. (3 from 2,405 patents)
8. Tanabe Seiyaku Company, Limited (2 from 324 patents)
9. Mitsubishi Tanabe Pharma Corporation (1 from 257 patents)
10. Organovo, Inc. (1 from 31 patents)
11. Eli Lilly and Company (4,442 patents)
12. F. Hoffmann-la Roche Ag (168 patents)
57 patents:
1. 12018008 - Crystalline forms of an androgen receptor modulator
2. 11773094 - Farnesoid X receptor agonists and uses thereof
3. 11236071 - Farnesoid X receptor agonists and uses thereof
4. 11214538 - Farnesoid X receptor agonists and uses thereof
5. 11084817 - Farnesoid X receptor agonists and uses thereof
6. 10961198 - Farnesoid X receptor agonists and uses thereof
7. 10934271 - Crystalline forms of an androgen receptor modulator
8. 10927082 - Farnesoid X receptor agonists and uses thereof
9. 10766875 - Crystalline forms of an androgen receptor modulator
10. 10703712 - Farnesoid X receptor agonists and uses thereof
11. 10626081 - Farnesoid X receptor agonists and uses thereof
12. 10556882 - Crystalline forms of an androgen receptor modulator
13. 10526310 - Crystalline forms of an androgen receptor modulator
14. 10377717 - Farnesoid X receptor agonists and uses thereof
15. 10308630 - Crystalline forms of an androgen receptor modulator